MedPath

A STUDY ON THALISATHY CHOORANAM (INTERNAL) AND LAGUVISHAMUTTI THYLAM(EXTERNAL) IN THE MANAGEMENT OF SAGANAVATHAM (CERVICALSPONDYLOSIS)

Phase 3
Not yet recruiting
Conditions
Other spondylosis,
Registration Number
CTRI/2023/02/049642
Lead Sponsor
National institute of siddha
Brief Summary

INTRODUCTION:

This is an open clinical trail that evaluates the effectiveness of siddha formulation THALISATHY CHOORANAM(INTERNAL) AND LAGUVISHAMUTTI THYLAM (EXTERNAL) in the management of SAGANAVATHAM(CERVICAL SPONDYLOSIS) patients through improvements in the neck disability index score and visual pain analog sacle before and after treatment. Cervical spondylosis is the result of osteoarthritis in the cervical spine. It is characterised by degeneration of the intervertebral discs and osteophyte formation. Osteoarthritis of the cervical spine may produce neck pain that radiates into the back of the head, shoulders, or arms, or may be the source of headaches in the posterior occipital region, and produces neck stiffness sometimes numbness or paresthesia of upper limbs. Spondylosis may be associated with neurological dysfunction. In order of frequency, the C5/6, C6/7 and C4/5 vertebral levels affect C6, C7 and C5 roots, respectively.

OUTCOME:

Improvement in neck disability index and Visual pain analog scale before and after treatment

MATERIALS AND METHODS:

A total of 10 diagnosed adult patients of SAGANAVATAHM(CERVICAL SPONDYLOSIS) willing to participate in the study , by signing the consent form will be enrolled in the study.Having neck pain radiating to back of head,top of shoulders,shoulder blades,upper arms and hands,neck stiffness and restricted movements of neck , numbness and paresthesia of neck or shoulders or upper limbs , the Neck Disability Index score should be equal or greater than 40%, patients who are willing to give radiological investigation will be included and K/H/O Traumatic injury,congenital spinal abnormalities,tuberculosis of spine ,cervical rib,adhesive capsulitis,ankylosing spondylitis,other ischemic heart disease,or renal disease , uncontrolled diabetes mellitus and pregnancy,lactation will be excluded.Assessment is done through neck disability index score and visual pain analog scale before and after treatment.

RESULTS AND DISCUSSION:

The result will be statistically analyzed

KEYWORDS:

Thalisathy chooranam,Saganavatham,Cervical spondylosis

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Neck pain radiating to back of head,top of shoulders,shoulder blades,upper arms and hands 2.
  • Neck stiffness and restricted movements of neck.
  • Numbness and paresthesia of neck or shoulders or upper limbs 4.
  • The Neck Disability Index score should be equal or greater than 40% 5.
  • Patient who are willing to sign informed consent form.
  • Patients who are willing to give radiological investigation.
Exclusion Criteria
  • Traumatic injury 2.
  • Ischemic heart diseases 3.Chronic Kidney disease 4.
  • Tuberculosis in spine 5.
  • Congenital spinal anomalies 6.
  • Pregnant women and lactating mothers.
  • Cervical Rib 8.
  • Ankylosing spondylitis 9.Adhesive capsulitis 10.Diabetes mellitus (uncontrolled).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
after treatment2 MONTHS- SCREENING | 2 MONTHS- DATA COLLECTION | 2 MONTHS- DATA ANALYSIS AND OUTCOME
The therapeutic efficacy of trial drug is assessed through improvement in neck disability index score and Visual pain analog scale before and2 MONTHS- SCREENING | 2 MONTHS- DATA COLLECTION | 2 MONTHS- DATA ANALYSIS AND OUTCOME
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ayothidoss Pandithar Hospital

🇮🇳

Kancheepuram, TAMIL NADU, India

Ayothidoss Pandithar Hospital
🇮🇳Kancheepuram, TAMIL NADU, India
Dr P Dhanakumari
Principal investigator
9524825994
dhanakumari1996@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.